The first domestic fat component product for special medical purposes -- Lanpei was approved for marketing

As the first formula food for special medical purposes developed, declared and finally approved by Languo Group, Lanpei® is the first special medical product registration approval issued in 2022, and it is also the first approved special medical non-food product in China.

MCT highlights the advantages  and greatly improves the compliance of patients with nutritional supplements

Fat is one of the indispensable nutrients for the human body, especially for some patients with specific diseases, because the body organs are in a disease state and there are metabolic disorders, they cannot obtain energy from ordinary food, which may cause severe malnutrition

Previously, a number of disease guidelines also provided evidence support for the clinical application of Lanpei®.

Taking inflammatory bowel disease (IBD) as an example, 55% of patients are prone to malnutrition, especially the incidence of malnutrition in children with IBD is as high as 100%.

At the annual meeting of the Chinese Medical Doctor Association's Intensive Medicine Physician Branch and the China Critical Care Medicine Conference held in early January 2022, Languo Group brought Lanpei® to the satellite conference on the theme of "Smart ICU and Intensive Nutrition Support".

The development of the special medical food industry has entered the fast lane  , and Languo Group achieves differentiated development with innovative products

As the value of special medical food in nutritional supplements and clinical treatment continues to be excavated, its clinical application value has also shifted from nutritional supplements to "a part of treatment"

At present, the relevant national regulatory authorities have set relatively high standards for the registration requirements, R&D and production, whole-item inspection, GMP plant and equipment of special medical food

As an innovative technology enterprise that is deeply engaged in special medical food, Languo Group has achieved differentiated development in the special medical food industry with innovative products by relying on its own technological research and development advantages.

With the official approval of the Lanpei® special medical fat component formula food of Languo Group, Languo Group will continue to develop the fat segment market in the future, and develop more fat series in strict accordance with the food management standards for special medical purposes.